In contrast, the unweighted 1–4 score—assigning one point per abnormal domain without empirical weighting— showed a weaker association and did not reach statistical significance ( Table 3 ).
← all excerpts
Baseline Composite Score for 12-Month Clinical Remission in Biologic-Treated Severe Asthma: Development of the Base4Score.
2
—
—
The sentences
Remission occurred in 8/20 (40.0%) of patients with low baseline scores (<5), 3/17 (17.6%) of those with intermediate scores (5–<9), and only 5/40 (12.5%) of patients with high scores (≥9), with a significant trend across categories (linear p -trend = 0.022).